EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...
The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...
First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3KdThe European Medicines Agency (EMA) has granted Orphan Drug Designation for roginolisib for treatment ...
The EU lacks cohesive governance to deploy economic statecraft tools, such as sanctions and export controls, undermining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback